06/08/2026
Pull your last three GLP-1 cancellations. Count how many trace back to nausea nobody prepared the patient for.
Most GLP-1 nausea is common, temporary, and manageable. Smaller meals. Slower eating. Plain food on the rough days, fluids between meals.
Patients rarely know any of that unless someone tells them, and the telling has a deadline: before week two, not after the complaint lands in the portal.
By the time it reads as a complaint, it has often already been decided as a cancellation. The chart logs a side effect. The revenue line logs a preventable quiet quit.
Two things worth checking in your own program this week.
One. Who tells a new patient what normal nausea looks like, and when? If the answer is "at the visit, if there is time," the answer is nobody.
Two. The red-flag version. Repeated vomiting, fluids not staying down. That needs a same-day pathway to your clinical team, not a spot in the portal queue. Patients forgive a rough week. They do not forgive feeling alone in it.
Expectations, set early, are a retention drug. The clinics that put that one conversation in week one keep patients the medication was never going to lose.
So, a real question for the room: what does a patient in your program hear about nausea before the first rough day, and who says it?
And if you want the drop-off priced in your own numbers, ask for the audit. The findings are yours either way.